Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franklin A Valdera

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Surgical Research|March 3, 2023
Outcomes of Partial Versus Total Colectomy in Ulcerative Colitis: A Propensity Score-Matched AnalysisElizabeth L Carpenter, Franklin A Valdera, Matthew V Chauviere, et al.
Military Medicine|September 30, 2023
Evaluation of Topical Off-the-Shelf Therapies to Reduce the Need to Evacuate Battlefield-Injured WarfightersDavid Larson, Anders H Carlsson, Franklin A Valdera, et al.
Journal of Surgical Education|December 25, 2021
Surgical Society Podcasts: A Novel Way to Engage and Educate the CommunityElizabeth L Carpenter, Franklin A Valdera, Jessica A Zaman, et al.
Military Medicine|May 5, 2022
Evaluation of Topical Off-The-Shelf Therapies to Improve Prolonged Field Care of Burn-Injured Service MembersDavid E Varon, Anders H Carlsson, Laura E Cooper, et al.
The Journal of Surgical Research|July 9, 2023
Topical Synthetic Platelets Loaded With Gentamicin Decrease Bacteria in Deep Partial-Thickness BurnsFranklin A Valdera, Kristo Nuutila, David E Varon, et al.
Clinical Immunology (Orlando, Fla.)|August 16, 2022
Immunologic and dose dependent effects of rapamycin and its evolving role in chemopreventionAnne E O'Shea, Franklin A Valdera, Daniel Ensley, et al.
Journal of Surgical Oncology|May 27, 2024
The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapyElizabeth L Carpenter, Spencer G Van Decar, Patrick M McCarthy, et al.
Frontiers in Immunology|March 24, 2023
Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trialsPatrick M McCarthy, Franklin A Valdera, Todd R Smolinsky, et al.
Journal of Surgical Oncology|October 6, 2023
Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing mattersFranklin A Valdera, Anne E O'Shea, Todd R Smolinsky, et al.
Cancer Immunology, Immunotherapy : CII|August 31, 2022
Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trialAlexandra M Adams, Elizabeth L Carpenter, Guy T Clifton, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Surgical Research|March 3, 2023
Outcomes of Partial Versus Total Colectomy in Ulcerative Colitis: A Propensity Score-Matched AnalysisElizabeth L Carpenter, Franklin A Valdera, Matthew V Chauviere, et al.
Military Medicine|September 30, 2023
Evaluation of Topical Off-the-Shelf Therapies to Reduce the Need to Evacuate Battlefield-Injured WarfightersDavid Larson, Anders H Carlsson, Franklin A Valdera, et al.
Journal of Surgical Education|December 25, 2021
Surgical Society Podcasts: A Novel Way to Engage and Educate the CommunityElizabeth L Carpenter, Franklin A Valdera, Jessica A Zaman, et al.
Military Medicine|May 5, 2022
Evaluation of Topical Off-The-Shelf Therapies to Improve Prolonged Field Care of Burn-Injured Service MembersDavid E Varon, Anders H Carlsson, Laura E Cooper, et al.
The Journal of Surgical Research|July 9, 2023
Topical Synthetic Platelets Loaded With Gentamicin Decrease Bacteria in Deep Partial-Thickness BurnsFranklin A Valdera, Kristo Nuutila, David E Varon, et al.
Clinical Immunology (Orlando, Fla.)|August 16, 2022
Immunologic and dose dependent effects of rapamycin and its evolving role in chemopreventionAnne E O'Shea, Franklin A Valdera, Daniel Ensley, et al.
Journal of Surgical Oncology|May 27, 2024
The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapyElizabeth L Carpenter, Spencer G Van Decar, Patrick M McCarthy, et al.
Frontiers in Immunology|March 24, 2023
Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trialsPatrick M McCarthy, Franklin A Valdera, Todd R Smolinsky, et al.
Journal of Surgical Oncology|October 6, 2023
Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing mattersFranklin A Valdera, Anne E O'Shea, Todd R Smolinsky, et al.
Cancer Immunology, Immunotherapy : CII|August 31, 2022
Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trialAlexandra M Adams, Elizabeth L Carpenter, Guy T Clifton, et al.
Pageof 2